Harvard Bioscience, Inc. (HBIO)
NASDAQ·Healthcare·Medical - Instruments & Supplies
$6.31
-4.97%
Mkt Cap $21.73M
Analyst Ratings
No recent rating data.
Price Target (2 analysts)
$0.60
Range $0.60 – $0.60
Implied Upside
-90.5%
Consensus $0.60 vs current $6.31